Compugen (CGEN) Liabilities and Shareholders Equity (2009 - 2026)

Compugen has disclosed Liabilities and Shareholders Equity across 18 years of filings, most recently posting $145.9 million for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $145.9 million, up 26.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $506.8 million (up 9.2% YoY), and the FY2025 annual result was $156.6 million, up 36.15% from the prior year.
• Liabilities and Shareholders Equity came in at $145.9 million for Q1 2026 at Compugen, down from $156.6 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $156.6 million in Q4 2025 to a low of $67.6 million in Q3 2023.
• The 5-year median for Liabilities and Shareholders Equity is $110.3 million (2022), against an average of $109.4 million.
• Across the five-year window, Liabilities and Shareholders Equity slumped 31.96% in 2023 and jumped 82.69% in 2024, its largest moves.
• Compugen's Liabilities and Shareholders Equity stood at $94.2 million in 2022, then rose by 28.84% to $121.3 million in 2023, then retreated by 5.22% to $115.0 million in 2024, then soared by 36.15% to $156.6 million in 2025, then fell by 6.84% to $145.9 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $145.9 million (Q1 2026), $156.6 million (Q4 2025), and $97.8 million (Q3 2025), per Business Quant data.